|
|
Volumn 30, Issue 30, 2012, Pages 4409-4413
|
|
Carbohydrate moieties as vaccine candidates: Targeting the sweet spot in the immune response
a
|
|
Author keywords
Adjuvants; Carbohydrate moieties; Glycans; Glycomics; Immune response; Vaccine
|
|
Indexed keywords
ADVAX;
ANTIGEN;
APRIL PROTEIN;
B CELL ACTIVATING FACTOR;
BACTERIAL POLYSACCHARIDE;
CARBOHYDRATE ANTIGEN;
CD40 LIGAND;
CD69 ANTIGEN;
CD71 ANTIGEN;
DIPHTHERIA TOXOID CRM197;
GANGLIOSIDE ANTIBODY;
GANGLIOSIDE GD2;
GANGLIOSIDE GD3;
GANGLIOSIDE GM2;
GROUP B STREPTOCOCCUS TYPE V POLYSACCHARIDE;
HAEMOPHILUS INFLUENZAE TYPE B VACCINE;
IMMUNOMODULATING AGENT;
INTERLEUKIN 10;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
MENINGOCOCCAL TYPE C POLYSACCHARIDE;
P10 GD2 MIMICKING PEPTIDE;
PANCARCINOMA CARBOHYDRATE TUMOR ASSOCIATED ANTIGEN;
PNEUMOCOCCUS VACCINE;
PROSTATE SPECIFIC ANTIGEN;
PS A1;
TRANSCRIPTION FACTOR FOXP3;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR ASSOCIATED CARBOHYDRATE ANTIGEN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VACCINE;
ADOPTIVE TRANSFER;
ANTIGEN PRESENTING CELL;
B LYMPHOCYTE;
BACILLUS ANTHRACIS;
BACTEROIDES FRAGILIS;
BORDETELLA PERTUSSIS;
BREAST CANCER;
CANCER GROWTH;
CANCER SURVIVAL;
CD25+ T LYMPHOCYTE;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELL LINEAGE;
CELL PROLIFERATION;
CITROBACTER FREUNDII;
CLOSTRIDIUM DIFFICILE;
CONFERENCE PAPER;
CPG ISLAND;
CYTOKINE PRODUCTION;
DOWN REGULATION;
DRUG DELIVERY SYSTEM;
DRUG DEVELOPMENT;
DRUG FORMULATION;
DRUG SAFETY;
DRUG TOLERABILITY;
ESCHERICHIA COLI;
FLOW CYTOMETRY;
GLYCOBIOLOGY;
HUMAN;
IMMUNE RESPONSE;
IMMUNITY;
IMMUNIZATION;
IMMUNOGENICITY;
IMMUNOGLOBULIN PRODUCTION;
IMMUNOTHERAPY;
IN VITRO STUDY;
INFLAMMATION;
LEISHMANIA MAJOR;
MAJOR HISTOCOMPATIBILITY COMPLEX;
METASTASIS;
NEISSERIA GONORRHOEAE;
NEISSERIA MENINGITIDIS;
NONHUMAN;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEOMICS;
REGULATORY T LYMPHOCYTE;
SALMONELLA ENTERICA;
SALMONELLA PARATYPHI;
SEROTYPE;
SIGNAL TRANSDUCTION;
STAPHYLOCOCCUS AUREUS;
TH1 CELL;
TRYPANOSOMA CRUZI;
TUMOR CELL;
VACCINATION;
YERSINIA PESTIS;
ADJUVANTS, IMMUNOLOGIC;
ANTIGENS, NEOPLASM;
CANCER VACCINES;
CARBOHYDRATES;
GLYCOMICS;
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (U.S.);
NATIONAL INSTITUTES OF HEALTH (U.S.);
POLYSACCHARIDES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
VACCINES;
|
|
EID: 84861998816
PISSN: 0264410X
EISSN: 18732518
Source Type: Journal
DOI: 10.1016/j.vaccine.2012.04.090 Document Type: Conference Paper |
|
Times cited : (11)
|
|
References (23)
|
